Atlas Trials

Northside Hospital, Inc.

27 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Northside Hospital, Inc.

RecordFirmDate
Axatilimab + CAR-T for High-Risk Lymphoma (NCT07638982)Northside Hospital, Inc.2026-10-31
Axatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated AML (NCT07511062)Northside Hospital, Inc.2026-08-01
Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant Cyclophosphamide (NCT06828796)Northside Hospital, Inc.2025-07-03
Adding Venetoclax to the High-dose Chemotherapy Regimen Prior to Mismatche Allogeneic Stem Cell Transplant (NCT06337331)Northside Hospital, Inc.2024-08-31
Belumosudil and Rituximab for Primary Treatment of Chronic Graft-Versus-Host-Disease (NCT06046248)Northside Hospital, Inc.2024-01-29
Intrathecal Chemoprophylaxis to Prevent Neurotoxicity Associated With Blinatumomab Therapy for Acute Lymphoblastic Leukemia (NCT05519579)Northside Hospital, Inc.2023-06-30
Use of Convalescent Plasma for COVID-19 (NCT04408040)Northside Hospital, Inc.2020-07-14
GM-CSF With Post-Transplant Cyclophosphamide (NCT04237623)Northside Hospital, Inc.2020-05-18
Ibrutinib and Rituxan for Chronic GVHD (NCT04235036)Northside Hospital, Inc.2019-12-16

Track Northside Hospital, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.